Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer

Published:2016-07-27 Issue:4 Volume:12 Page:388-395
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Lee Seok Ho¹,Kim Hun Jung²,Kim Woo Chul²

Affiliation:

1. Department of Radiation Oncology; Gachon University Gill Medical Center; Inchon South Korea

2. Department of Radiation Oncology, Inha University Hospital; Inha University of Medicine; Inchon South Korea

Funder

INHA University Hospital research

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12566/fullpdf

Reference45 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012;Jung;Cancer Res Treat,2015

3. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years;Katz;Radiat Oncol,2013

4. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience;Chen;Radiat Oncol,2013

5. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer;King;Int J Radiat Oncol Biol Phys,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Efficacy, toxicity, and quality‐of‐life outcomes of ultrahypofractionated radiotherapy in patients with localized prostate cancer: A single‐arm phase 2 trial from Asia;Asia-Pacific Journal of Clinical Oncology;2021-12-14

3. Strategies and methods for selecting suitable combined interventional therapy for pancreatic carcinoma;Integrative Pancreatic Intervention Therapy;2021

4. Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline;Journal of Clinical Oncology;2018-12-01

5. Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes;European Urology Oncology;2018-12